文献速递急性肾损伤慢性肾脏病

磁共振成像准确追踪急性肾损伤向慢性肾脏病转变中的肾脏病理与异质性

Magnetic resonance imaging accurately tracks kidney pathology and heterogeneity in the transition from acute kidney injury to chronic kidney disease.
PubMed 文献 · Kidney Int · 2020-09-08

该研究在小鼠模型中应用阳离子铁蛋白增强磁共振成像(CFE-MRI)追踪急性肾损伤(AKI)向慢性肾脏病(CKD)转变中的肾脏病理异质性。结果显示,尽管存在显著异质性,基于MRI的无创指标在区分AKI和CKD与对照组方面与有创组织学指标一样准确,且阳离子铁蛋白在CKD模型中未显示明显毒性。

要点

  • CFE-MRI可无创、准确地追踪AKI向CKD转变中的全肾病理变化。
  • MRI指标在区分AKI和CKD与对照组方面与组织学指标精度相当。
  • 阳离子铁蛋白在CKD-4模型中除增加肾、肝、脾铁含量外未显示明显毒性。

核心结论

  • CFE-MRI检测全肾病理的准确性和安全性得到证实,为AKI和CKD小鼠模型的纵向研究提供了基础。

研究设计与样本

  • 成年雄性小鼠接受叶酸后给予阳离子铁蛋白,分别在4天(AKI)、4周(CKD-4)或12周(CKD-12)处死。
  • 肾脏通过组织学方法和CFE-MRI检查。
  • 为评估阳离子铁蛋白在CKD模型中的毒性,CKD-4小鼠接受阳离子铁蛋白后一周检查。

主要发现

  • CKD-4和CKD-12组肾小球数量减少,并观察到无小管皮质病变。
  • AKI、CKD-4和CKD-12组的表观肾小球体积均大于对照组。
  • 肾小球肥大随衰老发生。
  • 肾小球间距和肾小球密度结合其他MRI指标可区分AKI和CKD组与对照组。
  • 尽管存在显著异质性,基于MRI的无创指标在区分AKI和CKD与对照组方面与有创组织学指标一样准确。

关键数值与推荐

  • CKD-4和CKD-12组肾小球数量减少,并出现无小管皮质病变。
  • AKI、CKD-4和CKD-12组的表观肾小球体积大于对照组。
  • MRI指标(包括肾小球间距和肾小球密度)可区分AKI和CKD组与对照组。
  • CKD-4加阳离子铁蛋白组肾、肝、脾铁含量高于不加组。

临床怎么用

  • CFE-MRI可作为无创工具检测AKI后肾脏微结构变化,有助于开发生物标志物。
  • 该技术为未来在小鼠模型中进行体内纵向研究以追踪肾单位命运提供了基础。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute kidney injury (AKI) increases the risk for chronic kidney disease (CKD). However, there are few tools to detect microstructural changes after AKI. Here, cationic ferritin-enhanced magnetic resonance imaging (CFE-MRI) was applied to examine the heterogeneity of kidney pathology in the transition from AKI to CKD. Adult male mice received folic acid followed by cationic ferritin and were euthanized at four days (AKI), four weeks (CKD-4) or 12 weeks (CKD-12). Kidneys were examined by histologic methods and CFE-MRI. In the CKD-4 and CKD-12 groups, glomerular number was reduced and atubular cortical lesions were observed. Apparent glomerular volume was larger in the AKI, CKD-4 and CKD-12 groups compared to controls. Glomerular hypertrophy occurred with ageing. Interglomerular distance and glomerular density were combined with other MRI metrics to distinguish the AKI and CKD groups from controls. Despite significant heterogeneity, the noninvasive (MRI-based) metrics were as accurate as invasive (histological) metrics at distinguishing AKI and CKD from controls. To assess the toxicity of cationic ferritin in a CKD model, CKD-4 mice received cationic ferritin and were examined one week later. The CKD-4 groups with and without cationic ferritin were similar, except the iron content of the kidney, liver, and spleen was greater in the CKD-4 plus cationic ferritin group. Thus, our study demonstrates the accuracy and safety of CFE-MRI to detect whole kidney pathology allowing for the development of novel biomarkers of kidney disease and providing a foundation for future in vivo longitudinal studies in mouse models of AKI and CKD to track nephron fate.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Charlton JR, Xu Y, Wu T, et al. Magnetic resonance imaging accurately tracks kidney pathology and heterogeneity in the transition from acute kidney injury to chronic kidney disease. Kidney Int. 2020. PMID: 32916180. doi:10.1016/j.kint.2020.08.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。